Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    Encaleret

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Encaleret Normalizes Calcium in Phase 2 Hypoparathyroidism Study
    Encaleret Normalizes Calcium in Phase 2 Hypoparathyroidism Study

    06 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/06/3145695/0/en/Encaleret-Showed-Parathyroid-Hormone-Independent-Normalization-of-Blood-and-Urine-Calcium-in-Phase-2-Proof-of-Concept-Study-in-Post-Surgical-Hypoparathyroidism.html

    GLOBENEWSWIRE
    06 Sep 2025
    Share Share
    BridgeBio to Unveil Encaleret Phase 2 Data in Post-Surgical
    BridgeBio to Unveil Encaleret Phase 2 Data in Post-Surgical

    02 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/02/3142538/0/en/BridgeBio-to-Present-Phase-2-Proof-of-Concept-Data-for-Encaleret-in-Post-Surgical-Hypoparathyroidism.html

    GLOBENEWSWIRE
    02 Sep 2025
    Share Share
    BridgeBio Announces New England Journal of Medicine Publication of Encaleret
    BridgeBio Announces New England Journal of Medicine Publication of Encaleret

    10 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/10/2757352/0/en/BridgeBio-Pharma-Announces-New-England-Journal-of-Medicine-Publication-of-Positive-Encaleret-Proof-of-Concept-Phase-2b-Results-in-Patients-with-Autosomal-Dominant-Hypocalcemia-Type.html

    GLOBENEWSWIRE
    10 Oct 2023
    Share Share
    BridgeBio: +ve PIIb Data, Announces Study Design for PIII Trial of Encaleret
    BridgeBio: +ve PIIb Data, Announces Study Design for PIII Trial of Encaleret

    13 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/13/2461142/0/en/BridgeBio-Pharma-Shares-Positive-Phase-2b-Data-and-Announces-Pivotal-Study-Design-for-Phase-3-Trial-of-Encaleret-in-Autosomal-Dominant-Hypocalcemia-Type-1-ADH1.html

    GLOBENEWSWIRE
    13 Jun 2022
    Share Share
    BridgeBio to Present PIIb Data & Pivotal PIII Study Design of Encaleret in ADH1
    BridgeBio to Present PIIb Data & Pivotal PIII Study Design of Encaleret in ADH1

    09 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/09/2459569/0/en/BridgeBio-Pharma-to-Present-Phase-2b-Data-and-Pivotal-Phase-3-Study-Design-of-Encaleret-in-Autosomal-Dominant-Hypocalcemia-Type-1-ADH1-at-the-Endocrine-Society-ENDO-2022-Annual-Con.html

    GLOBENEWSWIRE
    09 Jun 2022
    Share Share